BofA Raises Chemed Price Target to $555 From $550, Keeps Neutral Rating
BofA adjusted its price target on Chemed to $555 from $550 and maintained a neutral rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.